Either way, training with intention helps, and small strength gains still matter for how you look, feel, and move
The trial followed more than 300 participants for up to 64 weeks, and Whartons team saw, on average, a nearly 14 percent drop in body weight among people taking the drug
doi:10.1038/s41598-021-00654-3
Phase 3 data shows Retatrutide producing 28.7% loss at 68 weeks compared to Tirzepatides 20.9% at 72 weeks
Ehud Ur, an endocrinologist in Vancouver, said being able to prescribe generic semaglutide will be "very exciting," noting that semaglutide would be an effective medication for many of his patients, but they aren't on it because they can't afford it